Send Message
View as an RSS Feed
  • Discovery Labs initiates mid-stage study of KL4 surfactant therapy in premature infants  [View news story]
    Pretty sad company....churning the same hopes and dreams so the BOD can give themselves bonuses. Sooo pathetic... Same kabuki dance repeated over and over again at share owner expense merely to load BOD pockets.
    Dec 31, 2015. 07:55 AM | Likes Like |Link to Comment
  • Is The BioCryst Pharmaceuticals (BCRX) Recent Surge Irrational Exuberance?  [View article]
    DSCO comparison sort of scary. DSCO is a very poorly managed company with a clear history of collective stupidity punctuated by serial failures.
    Jul 31, 2015. 07:52 AM | Likes Like |Link to Comment
  • Arena - Belviq Sales Slide Again  [View article]
    Personally, I believe the consequences of Obamacare and Obama are beginning to be realized. Health insurance with high deductibles with even high costs coupled with the 2015 tax increases leaves quite a hole in budgets. "Forward" Obama's Greatest Depression.
    Jul 7, 2015. 07:36 AM | 2 Likes Like |Link to Comment
  • Key Takeaways From Antares Pharma's Q4 2014 Results  [View article]
    Nothing to see here... Just passing through...sorry about yawning so much...I apologize.
    Mar 18, 2015. 10:53 AM | 1 Like Like |Link to Comment
  • Bad News For Pfizer's Chantix May Be Good News For Arena's Belviq  [View article]
    There seems to be something else brewing here. .. One eyebrow raise salute to recent "activity" that even made spencer more jumpy than usual.
    Mar 13, 2015. 08:27 AM | Likes Like |Link to Comment
  • Bullish Action Leading Up To Discovery Laboratories Earnings  [View article]
    Dsco's management will screw up even the most basic opportunities. History is horrendous trail of failures
    Mar 12, 2015. 04:09 PM | 1 Like Like |Link to Comment
  • Arena - Belviq Ads Slow Substantially - Eisai Promises Seem To Be Fading  [View article]
    after serial mediocre roll out, suspect those who brought mediocre sales and income might be re evaluate their plans as others re evaluate them. Expect a change of direction verse more of the same. Decrease advertising looks like heads will be rolling more than a surrender.
    Mar 10, 2015. 06:07 AM | 3 Likes Like |Link to Comment
  • BioCryst Pharmaceuticals: BCX 4161 And Peramivir... Buyer Beware  [View article]
    "rapidity" said.
    Aug 15, 2013. 08:28 AM | Likes Like |Link to Comment
  • BioCryst: The Next Orphan Drug $1B+ Company  [View article]
    Baker Brothers have a clear and concise history of being lucky ..... that is why they are the Baker Brothers and people take notice of their positions.
    Aug 4, 2013. 10:34 AM | 1 Like Like |Link to Comment
  • Discovery Laboratories Stumbles  [View article]
    After Cooper's "next" reverse split and subsequent dilution, reality remains the exactly same.

    This company has a idle cash burn above and beyond the orphan indications ability to provide revenue with a management team that would make Bernie Madoff blush.

    Hard to believe these clowns are still sucking shareowner's dry.
    Apr 16, 2013. 07:41 AM | 4 Likes Like |Link to Comment
  • Discovery Laboratories: The Surfaxin Launch And Beyond  [View article]
    The company's management has always had problems implementing their elusive plans as documented by a history that rivals the Iliad.

    The company's current cash burn is huge inconsideration of their current and even projected income.

    Love the promise of the drug but, as I noted earlier, the promises of management simply do not add up now any better than they did last year or the previous decades.
    Mar 22, 2013. 08:05 AM | 1 Like Like |Link to Comment
  • 2013 Will Be A Telling Year For Discovery Laboratories  [View article]
    Ahhh...the promise of the pipeline. Heard the song and dance before. However, current management along with past management could not get'er done in the past decade. And, it has not the monies to do it in the future for the income from orphan drugs tends not to pay idle cash burn costs. Dilution is the solution....Cooper is the master of his domain....scary when the lab floor is so slippery.
    Jan 9, 2013. 04:13 PM | Likes Like |Link to Comment
  • Philip Morris Is Ready To Move Higher  [View article]
    In other words, "Overpriced for now"; And, " earnings will eventually get to the point in the future where it justifies current price". Unless, of course, current PPS decreases to the point it is supported by current earnings. Said it all without using way too many words.
    Jan 9, 2013. 04:06 PM | Likes Like |Link to Comment
  • Discovery Laboratories Announces Changing Of The Guard  [View article]
    BAT has alway been a problem and is the reason why Cappy high tailed it.

    So far, Cappy is the only one who made monies on this company besides the attorneys with the class action lawsuits.
    Jan 7, 2013. 09:11 AM | Likes Like |Link to Comment
  • Discovery Laboratories: Disappointment With Delay In Surfaxin Launch Creates An Opportunity  [View article]
    This company has had fumble after fumble. It is broke and the products approved, when and if they ever come to market, are orphan drugs that probably will not suffice to satisfy even idle cash burn of the company. Excellent product line developement is only possible when company is sold and the current management replaced by ash trays.
    Dec 18, 2012. 12:06 PM | 2 Likes Like |Link to Comment